click below
click below
Normal Size Small Size show me how
Pharm Chapter34
Pharmacology of Fungal Infections
| Question | Answer |
|---|---|
| MOA Flucytosine | flucytosine is converted to 5FdUMP, which inhibits thymidylate synthase and thereby interferes with DNA synthesis |
| clinical applications flucytosine | candidiasis, cryptococcosis, chromomycosis |
| Adverse effects flucytosine | Bone marrow suppression (leukopenia, thrombocytopenia), GI disturbance, hepatic dysfunction |
| Contraindications flucytosine, griseofulvin | pregnancy |
| In combination with what is flucytosine effective against Aspergillus? | Amphotericin B |
| MOA griseofulvin | binds to tubulin and a microtubule associated protein, thereby disrupting assembly of the mitotic spindle |
| Clinical applications griseofulvin | fungal infection of the skin hair, or nail due to Tricophyton, Microsporum, or Epidermophytan |
| Adverse effects griseofulvin | hepatotoxicity, albuminuria, leukopenia, neutropenia, monocytosis, seru sickness, angioedema, toxic epidermal necrolysis, headache, lethargy, vertigo, blurred vision (inc. with alcohol), increased fecal protoporphyrin levels |
| MOA terbinafine (allylamine), naftifine (allylamine), butenafine (benzylamine) | Inhibit conversion of squalene to lanosterol by inhibiting squalene epoxidase |
| Clinical applications terbinafine, naftifine, butenafine | Onychomycosis (terbinafine), tinea corporis, tinea cruris, tinea pedis, tinea capitis |
| Adverse effects terbinafine, naftifine, butenafine | hepatotoxicity, Stevens-Johnson syndrome, neutropenia, exacerbation of psoriasis or subacute cutaneous lupus erythmatosus (oral terbinafine) |
| Contraindication terbinafine | Renal or hepatic failure, pregnancy |
| Coadministration with what increases plasma levels of terbinafine? | cimetidine |
| Coadministration with what decreases plasma levels of terbinafine? | rifampin |
| Inhibitors of 14alpha-sterol demthylase | Imidazoles- ketoconazole, butoconazole, clotrimazole, econazole, miconazole, oxconazole, sertaconazole, sulconazole; Triazoles - fluconazole, itraconazole, posaconazole, terconazole, voriconazole |
| Clinical applications ketoconazole | Coccidioides immitis, Cryptococcus neoformans, Candida species, Histoplasma capsulatum , Blastomyces dermatitidis, variety of dermatophytes |
| Adverse effects ketoconazole | GI disturbance, hepatic dysfunction, gynecomastia, decreased libido, menstrual irregularities |
| Clinical applications butoconazole, clotrimazole, econazole, miconazole, oxconazole, sertaconazole, sulconazole | superficial fungal infections of the stratum corneum, squamous mucosa, and cornea |
| Adverse effects butoconazole, clotrimazole, econazole, miconazole, oxconazole, sertaconazole, sulconazole | Pruritus and burning |
| Clinical applications fluconazole | candidiasis, cryptococcal meningitis (inhibit P450 3A4) |
| Adverse effects fluconazole | nausea, vomiting, abdominal pain, diarrhea |
| Clinical applications itraconazole | aspergillosis, blstomycosis, candidiasis, histoplasmosis, onychomycosis (inhibit P450 3A4) |
| Adverse effects itraconazole | Hepatic toxicity, Stevens-Johnson syndrome, GI disturbance |
| Clinical applications posaconazole | aspergillosis, zygomycosis |
| Clinical applications terconazole | vaginal candidiasis |
| Clinical applications voriconazole | aspergillosis, candidiasis, Fusarium, Monosporium apiospermum |
| Adverse effects voriconazole | Hepatic toxicity, photophobia and colored lights |
| MOA polyenes - amphotericin B, nystatin | bind to ergosterol and form pores that alter fungal membrane permeability and stability |
| Clinical applications amphotericin B | Potentially life-threatening aspergillosis, crytococcosis, North AMercan blastomycoses, systemic candidiasis, coccidioidomycosis, histoplasmosis, systemic candidiasis, zygomycosis |
| Adverse effects amphotericin B | Renal toxicity (renal tubular acidosis, cylindruria, hypokalemia), cytokine storm (fever, chills, hypotension), anemia |
| Clinical applications nystatin | mucocutaneous candidiasis |
| MOA echinocandins- - caspofungin, micafungin, anidulafungin | Noncompetitively inhibit synthesis of Beta-(1,3)-D-glucans, which leads to disruption of cell wall integrity |
| Clinical applications caspofungin | esophageal candidiasis, candidemia, salvage therapy of Aspergillus infections, empiric therapy of febrile neutropenia |
| Clinical applications micafungin | esophageal candidiasis, antifungal prophylaxis for recipients of hematopoietic stem cell transplants |
| Clinical applications anidulafungin | esophageal candidiasis, candidemia |
| Adverse effects caspofungin, micafungin, anidulafungin | pruritus, rash, increased liver enzymes, headache, fever |
| Coadministration of what increases plasma concentration of caspofungin and elevates liver function enzymes? | cyclosporine |